1. Home
  2. RXST vs ICHR Comparison

RXST vs ICHR Comparison

Compare RXST & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXST
  • ICHR
  • Stock Information
  • Founded
  • RXST 1997
  • ICHR 1999
  • Country
  • RXST United States
  • ICHR United States
  • Employees
  • RXST N/A
  • ICHR N/A
  • Industry
  • RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ICHR Semiconductors
  • Sector
  • RXST Health Care
  • ICHR Technology
  • Exchange
  • RXST Nasdaq
  • ICHR Nasdaq
  • Market Cap
  • RXST 1.2B
  • ICHR 1.0B
  • IPO Year
  • RXST 2021
  • ICHR 2016
  • Fundamental
  • Price
  • RXST $29.60
  • ICHR $33.52
  • Analyst Decision
  • RXST Strong Buy
  • ICHR Strong Buy
  • Analyst Count
  • RXST 8
  • ICHR 7
  • Target Price
  • RXST $58.13
  • ICHR $43.00
  • AVG Volume (30 Days)
  • RXST 492.3K
  • ICHR 356.4K
  • Earning Date
  • RXST 02-25-2025
  • ICHR 02-04-2025
  • Dividend Yield
  • RXST N/A
  • ICHR N/A
  • EPS Growth
  • RXST N/A
  • ICHR N/A
  • EPS
  • RXST N/A
  • ICHR N/A
  • Revenue
  • RXST $128,293,000.00
  • ICHR $849,040,000.00
  • Revenue This Year
  • RXST $60.30
  • ICHR $19.19
  • Revenue Next Year
  • RXST $34.65
  • ICHR $11.56
  • P/E Ratio
  • RXST N/A
  • ICHR N/A
  • Revenue Growth
  • RXST 67.52
  • ICHR 4.68
  • 52 Week Low
  • RXST $26.29
  • ICHR $25.95
  • 52 Week High
  • RXST $66.54
  • ICHR $45.21
  • Technical
  • Relative Strength Index (RSI)
  • RXST 33.54
  • ICHR 56.61
  • Support Level
  • RXST $29.65
  • ICHR $31.33
  • Resistance Level
  • RXST $32.25
  • ICHR $35.56
  • Average True Range (ATR)
  • RXST 1.25
  • ICHR 1.63
  • MACD
  • RXST -0.14
  • ICHR 0.43
  • Stochastic Oscillator
  • RXST 4.66
  • ICHR 78.23

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, the United Kingdom, Singapore, Malaysia, Korea, and Mexico, of which a majority of the revenue is generated from Singapore.

Share on Social Networks: